Low rate of seroconversion after mRNA anti-SARS-CoV-2 vaccination in patients with hematological malignancies.
Daniel ReJérôme BarrièreEmmanuel ChamoreyMargaux DelforgeLauris GastaudEmmanuel PetitAxel ChaminadeBenjamin VerrièreFrédéric PeyradePublished in: Leukemia & lymphoma (2021)